EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis

Cancer Cell

Volumn 22, Issue 3, 2012, Pages 304-317

  Ardito, Christine M ^a   Grüner, Barbara M ^b   Takeuchi, Kenneth K ^c   Lubeseder Martellato, Clara ^b   Teichmann, Nicole ^b   Mazur, Pawel K ^d   DelGiorno, Kathleen E ^a,c   Carpenter, Eileen S ^a   Halbrook, Christopher J ^a,c   Hall, Jason C ^a,c   Pal, Debjani ^a   Briel, Thomas ^b   Herner, Alexander ^b   Trajkovic Arsic, Marija ^b   Sipos, Bence ^e   Liou, Geou Yarh ^c   Storz, Peter ^c   Murray, Nicole R ^c   Threadgill, David W ^f   Sibilia, Maria ^g   Washington, M Kay ^h   Wilson, Carole L ⁱ   Schmid, Roland M ^b   Raines, Elaine W ⁱ   Crawford, Howard C ^a,c,j   Siveke, Jens T ^b   more..

^a STONY BROOK UNIVERSITY   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MAYO CLINIC   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f NORTH CAROLINA STATE UNIVERSITY   (United States)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BAY 86 9766; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEMCITABINE; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CHRONIC PANCREATITIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; UPREGULATION;

EID: 84866007085     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.07.024     Document Type: Article

References (52)

1. Bardeesy N., Kim M., Xu J., Kim R.S., Shen Q., Bosenberg M.W., Wong W.H., Chin L. Role of epidermal growth factor receptor signaling in RAS-driven melanoma. Mol. Cell. Biol. 2005, 25:4176-4188.
2. Bardeesy N., Aguirre A.J., Chu G.C., Cheng K.H., Lopez L.V., Hezel A.F., Feng B., Brennan C., Weissleder R., Mahmood U., et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. USA 2006, 103:5947-5952.
3. Basu T., Warne P.H., Downward J. Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factor. Oncogene 1994, 9:3483-3491.
4. Carrière C., Young A.L., Gunn J.R., Longnecker D.S., Korc M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 2009, 382:561-565.
5. Castro A.F., Rebhun J.F., Quilliam L.A. Measuring Ras-family GTP levels in vivo-running hot and cold. Methods 2005, 37:190-196.
6. Collisson E.A., Sadanandam A., Olson P., Gibb W.J., Truitt M., Gu S., Cooc J., Weinkle J., Kim G.E., Jakkula L., et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 2011, 17:500-503.
7. De Lisle R.C., Logsdon C.D. Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner. Eur. J. Cell Biol. 1990, 51:64-75.
8. Dlugosz A.A., Hansen L., Cheng C., Alexander N., Denning M.F., Threadgill D.W., Magnuson T., Coffey R.J., Yuspa S.H. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res. 1997, 57:3180-3188.
9. Fjällskog M.L., Lejonklou M.H., Oberg K.E., Eriksson B.K., Janson E.T. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin. Cancer Res. 2003, 9:1469-1473.
10. Friess H., Berberat P., Schilling M., Kunz J., Korc M., Büchler M.W. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J. Mol. Med. 1996, 74:35-42.
11. Gale N.W., Kaplan S., Lowenstein E.J., Schlessinger J., Bar-Sagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 1993, 363:88-92.
12. Gangarosa L.M., Sizemore N., Graves-Deal R., Oldham S.M., Der C.J., Coffey R.J. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J. Biol. Chem. 1997, 272:18926-18931.
13. Gidekel Friedlander S.Y., Chu G.C., Snyder E.L., Girnius N., Dibelius G., Crowley D., Vasile E., DePinho R.A., Jacks T. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 2009, 16:379-389.
14. Guerra C., Schuhmacher A.J., Cañamero M., Grippo P.J., Verdaguer L., Pérez-Gallego L., Dubus P., Sandgren E.P., Barbacid M. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007, 11:291-302.
15. Guerra C., Collado M., Navas C., Schuhmacher A.J., Hernández-Porras I., Cañamero M., Rodriguez-Justo M., Serrano M., Barbacid M. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011, 19:728-739.
16. Hansen L.A., Woodson R.L., Holbus S., Strain K., Lo Y.C., Yuspa S.H. The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res. 2000, 60:3328-3332.
17. Heid I., Lubeseder-Martellato C., Sipos B., Mazur P.K., Lesina M., Schmid R.M., Siveke J.T. Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology 2011, 141:719-730.
18. Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., Ross S., Conrads T.P., Veenstra T.D., Hitt B.A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003, 4:437-450.
19. Iverson C., Larson G., Lai C., Yeh L.T., Dadson C., Weingarten P., Appleby T., Vo T., Maderna A., Vernier J.M., et al. RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer. Cancer Res. 2009, 69:6839-6847.
20. Jaganathan S., Yue P., Turkson J. Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or Src. J. Pharmacol. Exp. Ther. 2010, 333:373-381.
21. Ji B., Tsou L., Wang H., Gaiser S., Chang D.Z., Daniluk J., Bi Y., Grote T., Longnecker D.S., Logsdon C.D. Ras activity levels control the development of pancreatic diseases. Gastroenterology 2009, 137:1072-1082.
22. Jimeno A., Tan A.C., Coffa J., Rajeshkumar N.V., Kulesza P., Rubio-Viqueira B., Wheelhouse J., Diosdado B., Messersmith W.A., Iacobuzio-Donahue C., et al. Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. Cancer Res. 2008, 68:2841-2849.
23. Kawaguchi Y., Cooper B., Gannon M., Ray M., MacDonald R.J., Wright C.V. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 2002, 32:128-134.
24. Kobrin M.S., Funatomi H., Friess H., Buchler M.W., Stathis P., Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun. 1994, 202:1705-1709.
25. Korc M., Friess H., Yamanaka Y., Kobrin M.S., Buchler M., Beger H.G. Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma. Gut 1994, 35:1468-1473.
26. Larbouret C., Robert B., Navarro-Teulon I., Thèzenas S., Ladjemi M.Z., Morisseau S., Campigna E., Bibeau F., Mach J.P., Pèlegrin A., Azria D. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas. Clin. Cancer Res. 2007, 13:3356-3362.
27. Lee K.E., Bar-Sagi D. Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell 2010, 18:448-458.
28. Lee T.C., Threadgill D.W. Generation and validation of mice carrying a conditional allele of the epidermal growth factor receptor. Genesis 2009, 47:85-92.
29. Lüttges J., Reinecke-Lüthge A., Möllmann B., Menke M.A., Clemens A., Klimpfinger M., Sipos B., Klöppel G. Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch. 1999, 435:461-468.
30. Marino S., Vooijs M., van Der Gulden H., Jonkers J., Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 2000, 14:994-1004.
31. Mascia F., Cataisson C., Lee T.C., Threadgill D., Mariani V., Amerio P., Chandrasekhara C., Souto Adeva G., Girolomoni G., Yuspa S.H., Pastore S. EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. J. Invest. Dermatol. 2010, 130:682-693.
32. Means A.L., Ray K.C., Singh A.B., Washington M.K., Whitehead R.H., Harris R.C., Wright C.V., Coffey R.J., Leach S.D. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology 2003, 124:1020-1036.
33. Means A.L., Meszoely I.M., Suzuki K., Miyamoto Y., Rustgi A.K., Coffey R.J., Wright C.V., Stoffers D.A., Leach S.D. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 2005, 132:3767-3776.
34. Miyamoto Y., Maitra A., Ghosh B., Zechner U., Argani P., Iacobuzio-Donahue C.A., Sriuranpong V., Iso T., Meszoely I.M., Wolfe M.S., et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003, 3:565-576.
35. Monick M.M., Cameron K., Staber J., Powers L.S., Yarovinsky T.O., Koland J.G., Hunninghake G.W. Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J. Biol. Chem. 2005, 280:2147-2158.
36. Moore M.J., Goldstein D., Hamm J., Figer A., Hecht J.R., Gallinger S., Au H.J., Murawa P., Walde D., Wolff R.A., et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 2007, 25:1960-1966. National Cancer Institute of Canada Clinical Trials Group.
37. Morris J.P., Cano D.A., Sekine S., Wang S.C., Hebrok M. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J. Clin. Invest. 2010, 120:508-520.
38. Natarajan A., Wagner B., Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. USA 2007, 104:17081-17086.
39. Normanno N., De Luca A., Bianco C., Strizzi L., Mancino M., Maiello M.R., Carotenuto A., De Feo G., Caponigro F., Salomon D.S. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366:2-16.
40. Pino M.S., Shrader M., Baker C.H., Cognetti F., Xiong H.Q., Abbruzzese J.L., McConkey D.J. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines. Cancer Res. 2006, 66:3802-3812.
41. Ringel J., Jesnowski R., Moniaux N., Lüttges J., Ringel J., Choudhury A., Batra S.K., Klöppel G., Löhr M. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Cancer Res. 2006, 66:9045-9053.
42. Sahin U., Weskamp G., Kelly K., Zhou H.M., Higashiyama S., Peschon J., Hartmann D., Saftig P., Blobel C.P. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 2004, 164:769-779.
43. Sandgren E.P., Luetteke N.C., Palmiter R.D., Brinster R.L., Lee D.C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990, 61:1121-1135.
44. Sharma A., Zangen D.H., Reitz P., Taneja M., Lissauer M.E., Miller C.P., Weir G.C., Habener J.F., Bonner-Weir S. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 1999, 48:507-513.
45. Sibilia M., Fleischmann A., Behrens A., Stingl L., Carroll J., Watt F.M., Schlessinger J., Wagner E.F. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 2000, 102:211-220.
46. Singh A.B., Harris R.C. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell. Signal. 2005, 17:1183-1193.
47. Siveke J.T., Einwächter H., Sipos B., Lubeseder-Martellato C., Klöppel G., Schmid R.M. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 2007, 12:266-279.
48. Strobel O., Dor Y., Alsina J., Stirman A., Lauwers G., Trainor A., Castillo C.F., Warshaw A.L., Thayer S.P. In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology 2007, 133:1999-2009.
49. Tang J., Zarbock A., Gomez I., Wilson C.L., Lefort C.T., Stadtmann A., Bell B., Huang L.C., Ley K., Raines E.W. Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites. Blood 2011, 118:786-794.
50. Tobita K., Kijima H., Dowaki S., Kashiwagi H., Ohtani Y., Oida Y., Yamazaki H., Nakamura M., Ueyama Y., Tanaka M., et al. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis. Int. J. Mol. Med. 2003, 11:305-309.
51. Zhao S., Wang Y., Cao L., Ouellette M.M., Freeman J.W. Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells. Int. J. Cancer 2010, 127:2076-2087.
52. Zhu Z., Kleeff J., Friess H., Wang L., Zimmermann A., Yarden Y., Büchler M.W., Korc M. Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem. Biophys. Res. Commun. 2000, 273:1019-1024.